.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Healthtrust
Deloitte
Daiichi Sankyo
US Army
Accenture
US Department of Justice
UBS
Medtronic
Argus Health

Generated: November 20, 2017

DrugPatentWatch Database Preview

Altaire Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ALTAIRE PHARMS INC, and what generic and branded alternatives to ALTAIRE PHARMS INC drugs are available?

ALTAIRE PHARMS INC has three approved drugs.



Summary for Altaire Pharms Inc

US Patents:0
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Altaire Pharms Inc
OFLOXACIN
ofloxacin
SOLUTION/DROPS;OPHTHALMIC202692-001Apr 29, 2013ATRXNoNo► Subscribe► Subscribe► Subscribe
Altaire Pharms Inc
DICLOFENAC SODIUM
diclofenac sodium
SOLUTION/DROPS;OPHTHALMIC203383-001Nov 16, 2015ATRXNoNo► Subscribe► Subscribe► Subscribe
Altaire Pharms Inc
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC078208-001Sep 27, 2010OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
McKinsey
Harvard Business School
Moodys
UBS
Merck
Fuji
Cantor Fitzgerald
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot